Inactive Instrument

Press Releases Aura Health Inc Toronto S.E.

Equities

GIR

CA5134413031

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Pharmadrug's Securedose Announces LOI with Canadian Controlled Drug Substance Licensed Dealer for Patent Pending Pharmaceutical Grade Cocaine	05-23	NE
PharmaDrug's Sairiyo Therapeutics Submits Clinical Trial Application for Phase 1 Study of Patented Reformulated Cepharanthine	05-15	NE
PharmaDrug Provides Forward Plan to Move Its Patent Pending Process and Formulation of Pharmaceutical Grade Biosynthetic Cocaine Through Development into Commercialization	05-13	NE
PharmaDrug Announces Director Appointment and Resignation	05-02	NE
PharmaDrug's Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine	05-01	NE
PharmaDrug's SecureDose Announces the Advancement of Process Development of Its Biosynthetic Formulation of Pharmaceutical Grade Cocaine	04-16	NE
PharmaDrug's SecureDose Announces Filing of US Provisional Patent for Manufacturing Method for Biosynthetic Pharmaceutical Grade Cocaine	03-13	NE
PharmaDrug Appoints Current Board Member Dr. David Kideckel as Chairman	02-27	NE
PharmaDrug's Sairiyo Successfully Demonstrates Ability to Manufacture Cepharanthine (PD-001) for Human Clinical Studies	02-14	NE
PharmaDrug Inc. Engages Investor Relations and Marketing Service Providers	02-12	NE
PharmaDrug Inc. Announces Successful Closing of Non-Brokered Private Placement	02-08	NE
PharmaDrug Inc. Announces Proposed Non-Brokered Private Placement	02-01	NE
PharmaDrug CEO Provides Vision for Securedose Acquisition	12-13	NE
PharmaDrug Inc. Completes Debt Restructuring	11-15	NE
PharmaDrug Inc. Announces Grant of Stock Options	11-08	NE
PharmaDrug Inc. Closes Acqusition of Securedose Synthetics	11-07	NE
PharmaDrug Inc. Enters Definitive Agreement to Acquire SecureDose Synthetics	27/10/23	NE
PharmaDrug Announces Share Consolidation and Change to Chief Financial Officer	20/10/23	NE
PharmaDrug Announces Amendment to Shareholder Meeting Matter	19/09/23	NE
PharmaDrug Provides Development Update of Cepharanthine (PD-001) for Cancer and Infectious Disease	14/09/23	NE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Aura Health Inc Toronto S.E.

Equities

GIR

CA5134413031

Press Releases

Filters